(Q40489384)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689443%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

review article

1 reference

title

Impact of the fluoroquinolones on gastrointestinal flora (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689443%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689443%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

author name string

B E Murray

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689443%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689443%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689443%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

45 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689443%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

125-133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7689443%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-199300453-00021

23 October 2019

exact match

0 references

cites work

Prevention of infections in neutropenic patients with pefloxacin

1 reference

12 December 2020

Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.

1 reference

12 December 2020

Fleroxacin: safety, tolerance and effect on the faecal flora of healthy volunteers

1 reference

12 December 2020

Suppression of the oropharyngeal and gastrointestinal microflora by ciprofloxacin: microbiological and clinical consequences

1 reference

12 December 2020

Ofloxacin for prevention of bacterial infections in granulocytopenic patients.

1 reference

12 December 2020

Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora

1 reference

12 December 2020

Effect of Sparfloxacin on Fecal Microflora and its Fecal Concentration in Patients with Bacillary Dysentery

1 reference

12 December 2020

CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria

1 reference

12 December 2020

Inactivation of quinolone by feces

1 reference

12 December 2020

Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacin.

1 reference

12 December 2020

Norfloxacin for selective decontamination: a study in human volunteers.

1 reference

12 December 2020

1 reference

12 December 2020

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Use of quinolones in the treatment of gastrointestinal infections

1 reference

12 December 2020

Pharmacokinetics of ofloxacin and the effect on the faecal flora of healthy volunteers.

1 reference

12 December 2020

In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin

1 reference

12 December 2020

Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora

1 reference

12 December 2020

Reduction of oral flora with ciprofloxacin in healthy volunteers

1 reference

12 December 2020

Effect of ofloxacin on oral and gastrointestinal microflora in patients undergoing gastric surgery

1 reference

12 December 2020

A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora

1 reference

12 December 2020

The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens

1 reference

12 December 2020

Effect of oral ofloxacin on fecal bacteria in human volunteers

1 reference

12 December 2020

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1 reference

12 December 2020

Recovery of pefloxacin in saliva and feces and its action on oral and fecal floras of healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora

1 reference

12 December 2020

Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract

1 reference

12 December 2020

In vitro activity of sparfloxacin

1 reference

12 December 2020

Effect of lomefloxacin on the normal oral and intestinal microflora

1 reference

12 December 2020

Impact of oral ciprofloxacin on the faecal flora of healthy volunteers

1 reference

12 December 2020

The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.

1 reference

12 December 2020

Impact of fluoroquinolones on the gastrointestinal flora

1 reference

12 December 2020

Pharmacokinetic study of lomefloxacin and its effect on the faecal flora of volunteers.

1 reference

12 December 2020

Ciprofloxacin concentrations and impact of the colon microflora in patients undergoing colorectal surgery

1 reference

12 December 2020

Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients

1 reference

12 December 2020

Ciprofloxacin: an update on clinical experience.

1 reference

12 December 2020

Clostridium difficile-associated diarrhea after norfloxacin

1 reference

12 December 2020

Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers

1 reference

12 December 2020

Transintestinal elimination of ciprofloxacin

1 reference

12 December 2020

Pharmacokinetics of quinolones: Newer aspects

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.

1 reference

12 December 2020

Ofloxacin and the gastrointestinal tract: a potential role in the treatment of bacterial enteritis

1 reference

12 December 2020

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

12 December 2020

Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers

1 reference

12 December 2020

Antibacterial activity of lomefloxacin

1 reference

12 December 2020

Considerations for the prevention of infectious complications in patients with cancer.

1 reference

12 December 2020

Norfloxacin binds to human fecal material

1 reference

12 December 2020

Influence of quinolones on throat- and faecal flora of healthy volunteers

1 reference

12 December 2020

Manipulation of the oropharyngeal and intestinal microflora by norfloxacin: microbiological and clinical aspects.

1 reference

12 December 2020

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens

1 reference

12 December 2020

Comparative in vitro activity of PD 127391, a new fluoroquinolone agent, against susceptible and resistant clinical isolates of gram-positive cocci

1 reference

12 December 2020

Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents

1 reference

12 December 2020

Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics

1 reference

12 December 2020

Newly documented antimicrobial activity of quinolones

1 reference

12 December 2020

Intestinal microflora changes induced by ciprofloxacin and treatment of portal-systemic encephalopathy (PSE)

1 reference

12 December 2020

Chemoprophylaxis of gram-negative infections in neutropenic patients

1 reference

12 December 2020

Clinical impact of newer quinolones: influence on normal microflora

1 reference

12 December 2020

In vitro activities of three of the newer quinolones against anaerobic bacteria

1 reference

12 December 2020

Influence of ciprofloxacin on the colonic microflora in young and elderly volunteers: no impact of the altered drug absorption

1 reference

12 December 2020

Gut decontamination by oral ofloxacin and ciprofloxacin in healthy volunteers.

1 reference

12 December 2020

Effect of oral ciprofloxacin on the faecal flora of healthy volunteers.

1 reference

12 December 2020

The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms

1 reference

12 December 2020

Effect of enoxacin on colonic microflora of healthy volunteers

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone

1 reference

12 December 2020

Norfloxacin versus placebo for prophylaxis against travellers' diarrhoea

1 reference

12 December 2020

Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea.

1 reference

12 December 2020

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers

1 reference

12 December 2020

Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora

1 reference

12 December 2020

Effects of norfloxacin on the faecal flora in patients with complicated urinary tract infections

1 reference

12 December 2020

Quinolones and the gastrointestinal tract

1 reference

12 December 2020